Austedo Prior Authorization: Key Criteria Health Plans May Use

Clinical Indications and Diagnostic Criteria for Prior Authorization

Prior authorization criteria that relate to clinical indications commonly reference regulatory approvals and accepted diagnostic frameworks. For movement disorder and dyskinesia-related indications, plans may request documentation linking a patient’s signs and symptoms to the specific indication cited in the request. This can include clinician notes describing symptom pattern, onset, and functional impact. Where rating scales are widely used, plans may request baseline scores to demonstrate severity. The intent is to align clinical presentation with the scope of coverage language in a given policy and to provide objective context for the treatment request.

Diagnostic criteria submissions often use established assessment tools to provide structured evidence. For example, clinician-administered scales or standardized dyskinesia assessments may be cited by prescribers to characterize severity. When disorders have overlapping features, plans may request clarifying documentation to differentiate diagnoses. Diagnostic imaging or laboratory tests are less commonly central for certain movement disorders, but specialist evaluations and exam findings typically carry weight. Clear, dated documentation that shows how the diagnosis was determined may streamline the review process.

In situations where an indication has well-defined subcriteria, health plans may require that each subcriterion is addressed in the submission. This can include documented duration of symptoms, specific functional impairments, and corroboration by specialist evaluation. Plans may also specify which documentation formats are acceptable—such as signed notes versus templated fields in an electronic prior authorization form. Submission of incomplete diagnostic narratives may prolong review, so many clinicians provide concise, structured summaries tied to the policy language.

When clinicians are preparing documentation for prior authorization, considering the plan’s stated diagnostic requirements can be helpful. Including clear dates, symptom trajectories, and measured baseline severity often aligns with payer expectations. Plans typically assess whether the requested therapy corresponds to the documented diagnosis and whether other diagnostic possibilities have been reasonably ruled out. Continuing to the next section, the discussion focuses on the types of clinical documentation and prior treatment history that plans commonly request.